Arnold, W. D., Morgen, J. J., Thomasen, P. B., Broch-Lips, M., Clark, L. A., Groennebaek, T., Skov, M.
, Winther, J. B., Ramadan, A., Rust, P. A., Myers, J. H., Darvishi, F. B., Dashtmian, A. R., Fish, L. A., Chugh, D., Bold, J., Quiroz, J., Hutchison, J., Nishimune, H. ... Clark, B. C. (2026).
Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition.
Journal of Clinical Investigation,
136(17), Article e190646.
https://doi.org/10.1172/JCI190646
Arotcarena, M. L., Fouka, M., Gialinaki, E. G., Giannopoulou, M., Jadot, H., Darricau, M., Lovisotto, A., Dovero, S., Planche, V., Balpe, E., Achour, M., Thiolat, M. L., Dutheil, N., Li, Q., Noe, E., Pioli, E. Y., Harhouri, K., Steinschneider, R., Kirik, D. ... Xilouri, M. (2026).
LAMP2A gene therapy mitigates Parkinson’s disease–related pathology in nonhuman primates.
Science Advances,
12(44), Article eaeg1787.
https://doi.org/10.1126/sciadv.aeg1787